Florian Grebien
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 33
- Acute Myeloid Leukemia Research 22
- Chronic Myeloid Leukemia Treatments 11
- Genetics 11
- Chronic Lymphocytic Leukemia Research 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Co-authors
- Giulio Superti‐FurgaOliver HantschelHartmut BeugRichard MorigglErnst W. MüllnerHelmut DolznigKeiryn L. BennettInes Kaupe
- Journals
- Blood (8 papers)Nature Communications (6 papers)HemaSphere (5 papers)Leukemia (4 papers)Scientific Reports (2 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Florian Grebien
60 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 111
- Hematology 793
- Genetics 448
- Molecular Biology 1.3k
- Oncology 450
- Immunology 323
Countries citing papers authored by Florian Grebien
This map shows the geographic impact of Florian Grebien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Grebien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Grebien more than expected).
Fields of papers citing papers by Florian Grebien
This network shows the impact of papers produced by Florian Grebien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Grebien. The network helps show where Florian Grebien may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Florian Grebien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 17 | |
| 7 | 2023 | 28 | |
| 8 | 2022 | 19 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 12 | |
| 11 | 2021 | 13 | |
| 12 | 2021 | 11 | |
| 13 | 2021 | 10 | |
| 14 | 2021 | 31 | |
| 15 | 2019 | 5 | |
| 16 | 2019 | 26 | |
| 17 | 2016 | 177 | |
| 18 | 2012 | 131 | |
| 19 | 2010 | 128 | |
| 20 | 2008 | 156 |
About Florian Grebien
Florian Grebien is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Immunology, having authored 62 papers that have together received 2.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Protein Degradation and Inhibitors (15 papers), Chronic Myeloid Leukemia Treatments (11 papers), Cytokine Signaling Pathways and Interactions (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Genomics and Chromatin Dynamics (6 papers), Epigenetics and DNA Methylation (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). The work is most often cited by research in Hematology (793 citations), Genetics (448 citations), Molecular Biology (1.3k citations), Oncology (450 citations) and Immunology (323 citations). Florian Grebien has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Giulio Superti‐Furga, Oliver Hantschel, Hartmut Beug, Richard Moriggl, Ernst W. Müllner, Helmut Dolznig, Keiryn L. Bennett, Ines Kaupe, Boris Kovačic and Johannes Schmoellerl. Their work appears in journals such as Blood, Nature Communications, HemaSphere, Leukemia and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.